Go online to PeerView.com/RZD860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in ophthalmology discusses improving patient outcomes in neovascular age-related macular degeneration. Upon completion of this activity, participants should be better able to: Recognize the burden associated with conventional anti-VEGF treatment regimens for neovascular AMD, Assess the latest clinical data (eg, efficacy, safety, maximum effective dosing interval) for approved neovascular AMD treatment regimens, Apply individualized treatment plans for patients with neovascular AMD, Identify clinical strategies to assess for and manage rare adverse events associated with anti-VEGF therapies.